FDA steers updated vaccine to focus on dominant omicron subvariants

FDA steers updated vaccine to focus on dominant omicron subvariants

Submitted by admin on June 30, 2022 - 10:08pm
Source: 
Beckers Hospital Review
News Tags: 
FDA
vaccines
COVID-19
Omicron BA.4
Omicron BA.5
Headline: 
FDA steers updated vaccine to focus on dominant omicron subvariants
snippet: 

The FDA told vaccine manufacturers June 30 to focus on leading omicron subvariants BA.4 and BA.5, two days after an independent panel voted to recommend modified omicron-targeted vaccines.

Do Not Allow Advertisers to Use My Personal information